Literature DB >> 26713542

Characteristics of Children With Cancer Discharged or Admitted From the Emergency Department.

Emily L Mueller1,2, Matthew Hall3, Samir S Shah4, Keith J August5, Mohamed A Radhi5, Michelle L Macy6,7.   

Abstract

BACKGROUND: Emergency department (ED) utilization by children with cancer is poorly understood. Among children with cancer, we explored reasons for ED visits and factors associated with admission within U.S. children's hospitals.
METHODS: A retrospective study of the 2011-2013 Pediatric Health Information System (PHIS) was conducted. Eligible ED visits included those within 365 days from the first inpatient encounter with an International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) code for cancer. Patient characteristics and reasons for ED visits were assessed. Factors associated with admission from the ED were examined with multivariable regression.
RESULTS: There were 26,770 ED visits by 17,943 children with cancer at 39 children's hospitals during the study period. Half of children with cancer visited the ED within 1 year after their first cancer hospitalization in PHIS. Fifty-six percent of ED visits resulted in admission. Fever or neutropenia accounted for the largest proportion of reasons for visits (34.6%). Risk factors for admission were as follows: "Other" race/ethnicity as compared to white, non-Hispanic (odds ratio [OR] = 1.4, 95% confidence interval [CI] 1.2-1.6), history of transplant (OR = 1.7, 95% CI 1.4-2.1), and ED visits reasons including neutropenia (OR = 43.4, 95% CI 36.0-52.3), blood stream infection (OR = 3.3, 95% CI 2.8-3.9), pancytopenia (OR = 28.8, 95% CI 18.1-45.9), dehydration (OR = 2.3, 95% CI 1.9-2.9), or pneumonia (OR = 3.8, 95% CI 2.8-5.1).
CONCLUSIONS: Children with cancer have high ED usage within 1 year after their first cancer hospitalization. Age, demographic factors, and reasons for ED visits significantly impacted admission from the ED. Further research should focus on ED utilization among children with cancer.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  adolescent; child; febrile neutropenia; oncology; supportive care

Mesh:

Year:  2015        PMID: 26713542     DOI: 10.1002/pbc.25872

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

1.  Title: The Children's Oncology Planning for Emergencies (COPE) Tool: Prototyping with Caregivers of Children with Cancer.

Authors:  Emily L Mueller; Anneli R Cochrane; Courtney M Moore; Andrew D Miller; Sarah E Wiehe
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

2.  Variation in hospital admission from the emergency department for children with cancer: A Pediatric Health Information System study.

Authors:  Emily L Mueller; Seethal A Jacob; Anneli R Cochrane; Aaron E Carroll; William E Bennett
Journal:  Pediatr Blood Cancer       Date:  2020-04-10       Impact factor: 3.167

3.  Assessing Needs and Experiences of Preparing for Medical Emergencies Among Children With Cancer and Their Caregivers.

Authors:  Emily L Mueller; Anneli R Cochrane; Courtney M Moore; Kelli B Jenkins; Nerissa S Bauer; Sarah E Wiehe
Journal:  J Pediatr Hematol Oncol       Date:  2020-11       Impact factor: 1.170

4.  An mHealth App to Support Caregivers in the Medical Management of Their Child With Cancer: Co-design and User Testing Study.

Authors:  Emily L Mueller; Anneli R Cochrane; Madison E Campbell; Sarah Nikkhah; Andrew D Miller
Journal:  JMIR Cancer       Date:  2022-03-16

Review 5.  Recognizing the emergency department's role in oncologic care: a review of the literature on unplanned acute care.

Authors:  Rebecca S Lash; Arthur S Hong; Janice F Bell; Sarah C Reed; Nicholas Pettit
Journal:  Emerg Cancer Care       Date:  2022-06-16

6.  Emergency Department Chief Complaints Among Children With Cancer.

Authors:  Megan D Burcham; Anneli R Cochrane; Seethal A Jacob; Aaron E Carroll; Emily L Mueller
Journal:  J Pediatr Hematol Oncol       Date:  2018-08       Impact factor: 1.289

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.